Document is current
Any future updates will be listed below
-
Authors
Dumbill, Richard https://orcid.org/0000-0003-1907-4758
Knight, Simon https://orcid.org/0000-0003-4837-9446
Hunter, James
Fallon, John https://orcid.org/0000-0002-8644-9380
Voyce, Daniel
Barrett, Jacob https://orcid.org/0009-0000-3946-816X
Ellen, Matt
Conroy, Elizabeth https://orcid.org/0000-0003-4858-727X
Roberts, Ian SD
James, Tim https://orcid.org/0000-0002-5382-9838
Allen, Gabrielle
Brook, Jennifer https://orcid.org/0000-0003-3594-8996
Weissenbacher, Annemarie https://orcid.org/0000-0002-0582-1815
Ploeg, Rutger https://orcid.org/0000-0001-7801-665X
Coussios, Constantin https://orcid.org/0000-0001-8792-7818
Friend, Peter https://orcid.org/0000-0003-0841-9685
-
Funding
Funding for this research was provided by:
DH | NIHR | Invention for Innovation (NIHR200022)
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 29 April 2025
First Online: 17 May 2025
Competing interests
: Peter Friend is a founder and is the Chief Medical Officer of OrganOx Ltd Constantin Coussios is a founder and is the Chief Technical Officer of OrganOx Ltd R.D., S.K. and J.F. have received consultancy fees from OrganOx Ltd for work outside the scope of this trial. The remaining authors declare no competing interests.
